Loading organizations...
Derming S.r.l. operates as a specialized clinical research institute, providing comprehensive evaluation services for the tolerability and efficacy of various products. The company primarily conducts dermatological examinations and develops tailored research protocols for clients within the cosmetic, pharmaceutical, and textile industries, ensuring product safety and performance through rigorous clinical trials. Its core offering involves independent testing and assessment of materials intended for human contact or consumption.
The institute was established to address the critical need for independent and scientifically sound product assessment. Dr. Adele Sparavigna, a medical doctor and dermatologist, serves as a prominent leader and chairman of Derming S.r.l. Her background and expertise in dermatology likely provided the foundational insight into the necessity of robust clinical testing for consumer and medical products, guiding the institute's specialized focus.
Derming S.r.l. serves a diverse clientele comprising manufacturers and developers in the cosmetics, pharmaceuticals, and textiles sectors seeking independent verification of their product claims. The company's vision centers on fostering innovation by providing trusted scientific validation, aiming to contribute to the development of safer, more effective products that meet stringent regulatory standards and consumer expectations globally.
Derming has 1 tracked investment across 1 company. The latest tracked deal is $940K Seed in Dermaself in September 2025.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 23, 2025 | Dermaself | $940K Seed | — | CDP Venture Capital, Stefano Molino, Urban Venture |